ACADIA Pharmaceuticals Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ACAD Nasdaq 2836 www.acadia.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ACADIA Pharmaceuticals Inc.

A Look At ACADIA Pharmaceuticals (ACAD) Valuation After Recent Share Price Weakness - Jun 7th, 2026 6:07 am
Acadia (ACAD) Down 3.7% Since Last Earnings Report: Can It Rebound? - Jun 5th, 2026 9:30 am
Is MYGN Stock a Buy at 0.4x Sales? What Investors Should Weigh - May 28th, 2026 7:20 am
MYGN Cancer Care Strategy: What's Driving 2026 Growth Plans - May 27th, 2026 6:48 am
ACADIA Pharmaceuticals Spotlights Alzheimer’s Psychosis Pipeline, NUPLAZID and DAYBUE Growth - May 19th, 2026 8:14 am
Shareholders In ACADIA Pharmaceuticals (NASDAQ:ACAD) Should Look Beyond Earnings For The Full Story - May 14th, 2026 4:58 am
ACADIA Pharmaceuticals Targets $1B Brand Opportunity as Key Neuropsychiatry Data Looms - May 12th, 2026 6:25 pm
Earnings Miss: ACADIA Pharmaceuticals Inc. Missed EPS By 58% And Analysts Are Revising Their Forecasts - May 11th, 2026 5:27 am
What ACADIA Pharmaceuticals (ACAD)'s Earnings Miss, EU Setback and R&D Transition Means For Shareholders - May 8th, 2026 9:17 pm
ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth - May 7th, 2026 9:42 am
ACADIA Pharmaceuticals Q1 Earnings Call Highlights - May 6th, 2026 4:57 pm
Acadia (ACAD) Q1 2026 Earnings Transcript - May 6th, 2026 4:46 pm
Acadia Pharmaceuticals (ACAD) Lags Q1 Earnings and Revenue Estimates - May 6th, 2026 3:25 pm
Acadia Pharmaceuticals Reports First Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance - May 6th, 2026 2:05 pm
ImmunityBio to Report Q1 Earnings: What's in the Cards? - May 4th, 2026 11:09 am
ACADIA (ACAD) Upgraded to Buy After Recent Pullback - May 2nd, 2026 11:51 am
Acadia Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development, Following a Distinguished Career - Apr 30th, 2026 2:05 pm
CSLLY vs. ACAD: Which Stock Is the Better Value Option? - Apr 30th, 2026 9:40 am
Iovance Biotherapeutics (IOVA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Apr 30th, 2026 8:00 am
Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy? - Apr 29th, 2026 8:00 am